Global Insulin Drug Delivery Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Insulin Drug Delivery Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 106

Published Date: 03 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

  • sp_icon1 sp_icon1_b Description
  • sp_icon2 sp_icon2_b Table of Contents
  • sp_icon3 sp_icon3_b Table of Figures
  • sp_icon4 sp_icon4_b Research Methodology
  • sp_icon1 sp_icon1_b Companies Mentioned
  • sp_icon1 sp_icon1_b Related Reports
  • sp_icon1 sp_icon1_b Product Tags
btl

Description

Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.

According to our (Global Info Research) latest study, the global Insulin Drug Delivery Devices market size was valued at USD 14380 million in 2022 and is forecast to a readjusted size of USD 19500 million by 2029 with a CAGR of 4.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Insulin Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Insulin Drug Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Insulin Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Insulin Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Insulin Drug Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Insulin Drug Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Insulin Drug Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, BD, Eli Lilly and Medtronic, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Insulin Drug Delivery Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Syringes
Insulin Pens
Jet Injectors
Insulin Pumps

Market segment by Application
Hospitals
Clinics
Homecare
Others

Major players covered
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Insulin Drug Delivery Devices, with price, sales, revenue and global market share of Insulin Drug Delivery Devices from 2018 to 2023.
Chapter 3, the Insulin Drug Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Insulin Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Insulin Drug Delivery Devices.
Chapter 14 and 15, to describe Insulin Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Insulin Drug Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Insulin Drug Delivery Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringes
1.3.3 Insulin Pens
1.3.4 Jet Injectors
1.3.5 Insulin Pumps
1.4 Market Analysis by Application
1.4.1 Overview: Global Insulin Drug Delivery Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Homecare
1.4.5 Others
1.5 Global Insulin Drug Delivery Devices Market Size & Forecast
1.5.1 Global Insulin Drug Delivery Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Insulin Drug Delivery Devices Sales Quantity (2018-2029)
1.5.3 Global Insulin Drug Delivery Devices Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Insulin Drug Delivery Devices Product and Services
2.1.4 Novo Nordisk Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Insulin Drug Delivery Devices Product and Services
2.2.4 Sanofi Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Insulin Drug Delivery Devices Product and Services
2.3.4 BD Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BD Recent Developments/Updates
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Insulin Drug Delivery Devices Product and Services
2.4.4 Eli Lilly Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eli Lilly Recent Developments/Updates
2.5 Medtronic
2.5.1 Medtronic Details
2.5.2 Medtronic Major Business
2.5.3 Medtronic Insulin Drug Delivery Devices Product and Services
2.5.4 Medtronic Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Medtronic Recent Developments/Updates
2.6 Beta Bionics
2.6.1 Beta Bionics Details
2.6.2 Beta Bionics Major Business
2.6.3 Beta Bionics Insulin Drug Delivery Devices Product and Services
2.6.4 Beta Bionics Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Beta Bionics Recent Developments/Updates
2.7 Dance Biopharm
2.7.1 Dance Biopharm Details
2.7.2 Dance Biopharm Major Business
2.7.3 Dance Biopharm Insulin Drug Delivery Devices Product and Services
2.7.4 Dance Biopharm Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Dance Biopharm Recent Developments/Updates
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Insulin Drug Delivery Devices Product and Services
2.8.4 Roche Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Recent Developments/Updates
2.9 Tandem Diabetes Care
2.9.1 Tandem Diabetes Care Details
2.9.2 Tandem Diabetes Care Major Business
2.9.3 Tandem Diabetes Care Insulin Drug Delivery Devices Product and Services
2.9.4 Tandem Diabetes Care Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Tandem Diabetes Care Recent Developments/Updates
2.10 Animas
2.10.1 Animas Details
2.10.2 Animas Major Business
2.10.3 Animas Insulin Drug Delivery Devices Product and Services
2.10.4 Animas Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Animas Recent Developments/Updates

3 Competitive Environment: Insulin Drug Delivery Devices by Manufacturer
3.1 Global Insulin Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Insulin Drug Delivery Devices Revenue by Manufacturer (2018-2023)
3.3 Global Insulin Drug Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Insulin Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Insulin Drug Delivery Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Insulin Drug Delivery Devices Manufacturer Market Share in 2022
3.5 Insulin Drug Delivery Devices Market: Overall Company Footprint Analysis
3.5.1 Insulin Drug Delivery Devices Market: Region Footprint
3.5.2 Insulin Drug Delivery Devices Market: Company Product Type Footprint
3.5.3 Insulin Drug Delivery Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Insulin Drug Delivery Devices Market Size by Region
4.1.1 Global Insulin Drug Delivery Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Insulin Drug Delivery Devices Consumption Value by Region (2018-2029)
4.1.3 Global Insulin Drug Delivery Devices Average Price by Region (2018-2029)
4.2 North America Insulin Drug Delivery Devices Consumption Value (2018-2029)
4.3 Europe Insulin Drug Delivery Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Insulin Drug Delivery Devices Consumption Value (2018-2029)
4.5 South America Insulin Drug Delivery Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Insulin Drug Delivery Devices Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
5.2 Global Insulin Drug Delivery Devices Consumption Value by Type (2018-2029)
5.3 Global Insulin Drug Delivery Devices Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
6.2 Global Insulin Drug Delivery Devices Consumption Value by Application (2018-2029)
6.3 Global Insulin Drug Delivery Devices Average Price by Application (2018-2029)

7 North America
7.1 North America Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
7.2 North America Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
7.3 North America Insulin Drug Delivery Devices Market Size by Country
7.3.1 North America Insulin Drug Delivery Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Insulin Drug Delivery Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
8.2 Europe Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
8.3 Europe Insulin Drug Delivery Devices Market Size by Country
8.3.1 Europe Insulin Drug Delivery Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Insulin Drug Delivery Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Insulin Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Insulin Drug Delivery Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
10.2 South America Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
10.3 South America Insulin Drug Delivery Devices Market Size by Country
10.3.1 South America Insulin Drug Delivery Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Insulin Drug Delivery Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Insulin Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Insulin Drug Delivery Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Insulin Drug Delivery Devices Market Drivers
12.2 Insulin Drug Delivery Devices Market Restraints
12.3 Insulin Drug Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Insulin Drug Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Insulin Drug Delivery Devices
13.3 Insulin Drug Delivery Devices Production Process
13.4 Insulin Drug Delivery Devices Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Insulin Drug Delivery Devices Typical Distributors
14.3 Insulin Drug Delivery Devices Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Insulin Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Insulin Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Insulin Drug Delivery Devices Product and Services
Table 6. Novo Nordisk Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Insulin Drug Delivery Devices Product and Services
Table 11. Sanofi Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. BD Basic Information, Manufacturing Base and Competitors
Table 14. BD Major Business
Table 15. BD Insulin Drug Delivery Devices Product and Services
Table 16. BD Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BD Recent Developments/Updates
Table 18. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly Major Business
Table 20. Eli Lilly Insulin Drug Delivery Devices Product and Services
Table 21. Eli Lilly Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Eli Lilly Recent Developments/Updates
Table 23. Medtronic Basic Information, Manufacturing Base and Competitors
Table 24. Medtronic Major Business
Table 25. Medtronic Insulin Drug Delivery Devices Product and Services
Table 26. Medtronic Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Medtronic Recent Developments/Updates
Table 28. Beta Bionics Basic Information, Manufacturing Base and Competitors
Table 29. Beta Bionics Major Business
Table 30. Beta Bionics Insulin Drug Delivery Devices Product and Services
Table 31. Beta Bionics Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Beta Bionics Recent Developments/Updates
Table 33. Dance Biopharm Basic Information, Manufacturing Base and Competitors
Table 34. Dance Biopharm Major Business
Table 35. Dance Biopharm Insulin Drug Delivery Devices Product and Services
Table 36. Dance Biopharm Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Dance Biopharm Recent Developments/Updates
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Insulin Drug Delivery Devices Product and Services
Table 41. Roche Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Roche Recent Developments/Updates
Table 43. Tandem Diabetes Care Basic Information, Manufacturing Base and Competitors
Table 44. Tandem Diabetes Care Major Business
Table 45. Tandem Diabetes Care Insulin Drug Delivery Devices Product and Services
Table 46. Tandem Diabetes Care Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Tandem Diabetes Care Recent Developments/Updates
Table 48. Animas Basic Information, Manufacturing Base and Competitors
Table 49. Animas Major Business
Table 50. Animas Insulin Drug Delivery Devices Product and Services
Table 51. Animas Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Animas Recent Developments/Updates
Table 53. Global Insulin Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Insulin Drug Delivery Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Insulin Drug Delivery Devices Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Insulin Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Insulin Drug Delivery Devices Production Site of Key Manufacturer
Table 58. Insulin Drug Delivery Devices Market: Company Product Type Footprint
Table 59. Insulin Drug Delivery Devices Market: Company Product Application Footprint
Table 60. Insulin Drug Delivery Devices New Market Entrants and Barriers to Market Entry
Table 61. Insulin Drug Delivery Devices Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Insulin Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Insulin Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Insulin Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Insulin Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Insulin Drug Delivery Devices Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Insulin Drug Delivery Devices Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Insulin Drug Delivery Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Insulin Drug Delivery Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Insulin Drug Delivery Devices Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Insulin Drug Delivery Devices Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Insulin Drug Delivery Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Insulin Drug Delivery Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Insulin Drug Delivery Devices Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Insulin Drug Delivery Devices Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Insulin Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Insulin Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Insulin Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Insulin Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Insulin Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Insulin Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Insulin Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Insulin Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Insulin Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Insulin Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Insulin Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Insulin Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Insulin Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Insulin Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Insulin Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Insulin Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Insulin Drug Delivery Devices Raw Material
Table 121. Key Manufacturers of Insulin Drug Delivery Devices Raw Materials
Table 122. Insulin Drug Delivery Devices Typical Distributors
Table 123. Insulin Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Insulin Drug Delivery Devices Picture
Figure 2. Global Insulin Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Insulin Drug Delivery Devices Consumption Value Market Share by Type in 2022
Figure 4. Syringes Examples
Figure 5. Insulin Pens Examples
Figure 6. Jet Injectors Examples
Figure 7. Insulin Pumps Examples
Figure 8. Global Insulin Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Insulin Drug Delivery Devices Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Homecare Examples
Figure 13. Others Examples
Figure 14. Global Insulin Drug Delivery Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Insulin Drug Delivery Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Insulin Drug Delivery Devices Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Insulin Drug Delivery Devices Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Insulin Drug Delivery Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Insulin Drug Delivery Devices Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Insulin Drug Delivery Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Insulin Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Insulin Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Insulin Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Insulin Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Insulin Drug Delivery Devices Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Insulin Drug Delivery Devices Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Insulin Drug Delivery Devices Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Insulin Drug Delivery Devices Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Insulin Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Insulin Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Insulin Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Insulin Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Insulin Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 56. China Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Insulin Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Insulin Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Insulin Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Insulin Drug Delivery Devices Market Drivers
Figure 77. Insulin Drug Delivery Devices Market Restraints
Figure 78. Insulin Drug Delivery Devices Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Insulin Drug Delivery Devices in 2022
Figure 81. Manufacturing Process Analysis of Insulin Drug Delivery Devices
Figure 82. Insulin Drug Delivery Devices Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts to verify insights.

Validation and
triangulation of
secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas
btl

Related Reports

shop_t

Purchase Options

jiaGou

Add To Cart

jiaGou

Buy Now

masterCard
visa
jcb
americanExpress
shop_b
Global Insulin Drug Delivery Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Global Insulin Drug Delivery Devices Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

Page: 106

Published Date: 03 Jan 2023

Category: Medical Devices & Consumables

PDF Download

Get FREE Sample

Customize Request

Description

arrow-d3
btl

Description

Insulin delivery devices that are currently available for the administration of insulin include syringes, insulin infusion pumps, jet injectors and pens.

According to our (Global Info Research) latest study, the global Insulin Drug Delivery Devices market size was valued at USD 14380 million in 2022 and is forecast to a readjusted size of USD 19500 million by 2029 with a CAGR of 4.4% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Insulin Drug Delivery Devices market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:
Global Insulin Drug Delivery Devices market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Insulin Drug Delivery Devices market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Insulin Drug Delivery Devices market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Insulin Drug Delivery Devices market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Insulin Drug Delivery Devices
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Insulin Drug Delivery Devices market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Novo Nordisk, Sanofi, BD, Eli Lilly and Medtronic, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market Segmentation
Insulin Drug Delivery Devices market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
Syringes
Insulin Pens
Jet Injectors
Insulin Pumps

Market segment by Application
Hospitals
Clinics
Homecare
Others

Major players covered
Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas

Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Insulin Drug Delivery Devices product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Insulin Drug Delivery Devices, with price, sales, revenue and global market share of Insulin Drug Delivery Devices from 2018 to 2023.
Chapter 3, the Insulin Drug Delivery Devices competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Insulin Drug Delivery Devices breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Insulin Drug Delivery Devices market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Insulin Drug Delivery Devices.
Chapter 14 and 15, to describe Insulin Drug Delivery Devices sales channel, distributors, customers, research findings and conclusion.
btl

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Insulin Drug Delivery Devices
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Insulin Drug Delivery Devices Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Syringes
1.3.3 Insulin Pens
1.3.4 Jet Injectors
1.3.5 Insulin Pumps
1.4 Market Analysis by Application
1.4.1 Overview: Global Insulin Drug Delivery Devices Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospitals
1.4.3 Clinics
1.4.4 Homecare
1.4.5 Others
1.5 Global Insulin Drug Delivery Devices Market Size & Forecast
1.5.1 Global Insulin Drug Delivery Devices Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Insulin Drug Delivery Devices Sales Quantity (2018-2029)
1.5.3 Global Insulin Drug Delivery Devices Average Price (2018-2029)

2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business
2.1.3 Novo Nordisk Insulin Drug Delivery Devices Product and Services
2.1.4 Novo Nordisk Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Novo Nordisk Recent Developments/Updates
2.2 Sanofi
2.2.1 Sanofi Details
2.2.2 Sanofi Major Business
2.2.3 Sanofi Insulin Drug Delivery Devices Product and Services
2.2.4 Sanofi Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Sanofi Recent Developments/Updates
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business
2.3.3 BD Insulin Drug Delivery Devices Product and Services
2.3.4 BD Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 BD Recent Developments/Updates
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business
2.4.3 Eli Lilly Insulin Drug Delivery Devices Product and Services
2.4.4 Eli Lilly Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Eli Lilly Recent Developments/Updates
2.5 Medtronic
2.5.1 Medtronic Details
2.5.2 Medtronic Major Business
2.5.3 Medtronic Insulin Drug Delivery Devices Product and Services
2.5.4 Medtronic Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Medtronic Recent Developments/Updates
2.6 Beta Bionics
2.6.1 Beta Bionics Details
2.6.2 Beta Bionics Major Business
2.6.3 Beta Bionics Insulin Drug Delivery Devices Product and Services
2.6.4 Beta Bionics Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Beta Bionics Recent Developments/Updates
2.7 Dance Biopharm
2.7.1 Dance Biopharm Details
2.7.2 Dance Biopharm Major Business
2.7.3 Dance Biopharm Insulin Drug Delivery Devices Product and Services
2.7.4 Dance Biopharm Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Dance Biopharm Recent Developments/Updates
2.8 Roche
2.8.1 Roche Details
2.8.2 Roche Major Business
2.8.3 Roche Insulin Drug Delivery Devices Product and Services
2.8.4 Roche Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Roche Recent Developments/Updates
2.9 Tandem Diabetes Care
2.9.1 Tandem Diabetes Care Details
2.9.2 Tandem Diabetes Care Major Business
2.9.3 Tandem Diabetes Care Insulin Drug Delivery Devices Product and Services
2.9.4 Tandem Diabetes Care Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Tandem Diabetes Care Recent Developments/Updates
2.10 Animas
2.10.1 Animas Details
2.10.2 Animas Major Business
2.10.3 Animas Insulin Drug Delivery Devices Product and Services
2.10.4 Animas Insulin Drug Delivery Devices Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Animas Recent Developments/Updates

3 Competitive Environment: Insulin Drug Delivery Devices by Manufacturer
3.1 Global Insulin Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023)
3.2 Global Insulin Drug Delivery Devices Revenue by Manufacturer (2018-2023)
3.3 Global Insulin Drug Delivery Devices Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Insulin Drug Delivery Devices by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Insulin Drug Delivery Devices Manufacturer Market Share in 2022
3.4.2 Top 6 Insulin Drug Delivery Devices Manufacturer Market Share in 2022
3.5 Insulin Drug Delivery Devices Market: Overall Company Footprint Analysis
3.5.1 Insulin Drug Delivery Devices Market: Region Footprint
3.5.2 Insulin Drug Delivery Devices Market: Company Product Type Footprint
3.5.3 Insulin Drug Delivery Devices Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region
4.1 Global Insulin Drug Delivery Devices Market Size by Region
4.1.1 Global Insulin Drug Delivery Devices Sales Quantity by Region (2018-2029)
4.1.2 Global Insulin Drug Delivery Devices Consumption Value by Region (2018-2029)
4.1.3 Global Insulin Drug Delivery Devices Average Price by Region (2018-2029)
4.2 North America Insulin Drug Delivery Devices Consumption Value (2018-2029)
4.3 Europe Insulin Drug Delivery Devices Consumption Value (2018-2029)
4.4 Asia-Pacific Insulin Drug Delivery Devices Consumption Value (2018-2029)
4.5 South America Insulin Drug Delivery Devices Consumption Value (2018-2029)
4.6 Middle East and Africa Insulin Drug Delivery Devices Consumption Value (2018-2029)

5 Market Segment by Type
5.1 Global Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
5.2 Global Insulin Drug Delivery Devices Consumption Value by Type (2018-2029)
5.3 Global Insulin Drug Delivery Devices Average Price by Type (2018-2029)

6 Market Segment by Application
6.1 Global Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
6.2 Global Insulin Drug Delivery Devices Consumption Value by Application (2018-2029)
6.3 Global Insulin Drug Delivery Devices Average Price by Application (2018-2029)

7 North America
7.1 North America Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
7.2 North America Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
7.3 North America Insulin Drug Delivery Devices Market Size by Country
7.3.1 North America Insulin Drug Delivery Devices Sales Quantity by Country (2018-2029)
7.3.2 North America Insulin Drug Delivery Devices Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe
8.1 Europe Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
8.2 Europe Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
8.3 Europe Insulin Drug Delivery Devices Market Size by Country
8.3.1 Europe Insulin Drug Delivery Devices Sales Quantity by Country (2018-2029)
8.3.2 Europe Insulin Drug Delivery Devices Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific
9.1 Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Insulin Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Insulin Drug Delivery Devices Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America
10.1 South America Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
10.2 South America Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
10.3 South America Insulin Drug Delivery Devices Market Size by Country
10.3.1 South America Insulin Drug Delivery Devices Sales Quantity by Country (2018-2029)
10.3.2 South America Insulin Drug Delivery Devices Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa
11.1 Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Insulin Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Insulin Drug Delivery Devices Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics
12.1 Insulin Drug Delivery Devices Market Drivers
12.2 Insulin Drug Delivery Devices Market Restraints
12.3 Insulin Drug Delivery Devices Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain
13.1 Raw Material of Insulin Drug Delivery Devices and Key Manufacturers
13.2 Manufacturing Costs Percentage of Insulin Drug Delivery Devices
13.3 Insulin Drug Delivery Devices Production Process
13.4 Insulin Drug Delivery Devices Industrial Chain

14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Insulin Drug Delivery Devices Typical Distributors
14.3 Insulin Drug Delivery Devices Typical Customers

15 Research Findings and Conclusion

16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
btl

Table of Figures

List of Tables
Table 1. Global Insulin Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Insulin Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 4. Novo Nordisk Major Business
Table 5. Novo Nordisk Insulin Drug Delivery Devices Product and Services
Table 6. Novo Nordisk Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Novo Nordisk Recent Developments/Updates
Table 8. Sanofi Basic Information, Manufacturing Base and Competitors
Table 9. Sanofi Major Business
Table 10. Sanofi Insulin Drug Delivery Devices Product and Services
Table 11. Sanofi Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Sanofi Recent Developments/Updates
Table 13. BD Basic Information, Manufacturing Base and Competitors
Table 14. BD Major Business
Table 15. BD Insulin Drug Delivery Devices Product and Services
Table 16. BD Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. BD Recent Developments/Updates
Table 18. Eli Lilly Basic Information, Manufacturing Base and Competitors
Table 19. Eli Lilly Major Business
Table 20. Eli Lilly Insulin Drug Delivery Devices Product and Services
Table 21. Eli Lilly Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Eli Lilly Recent Developments/Updates
Table 23. Medtronic Basic Information, Manufacturing Base and Competitors
Table 24. Medtronic Major Business
Table 25. Medtronic Insulin Drug Delivery Devices Product and Services
Table 26. Medtronic Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Medtronic Recent Developments/Updates
Table 28. Beta Bionics Basic Information, Manufacturing Base and Competitors
Table 29. Beta Bionics Major Business
Table 30. Beta Bionics Insulin Drug Delivery Devices Product and Services
Table 31. Beta Bionics Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Beta Bionics Recent Developments/Updates
Table 33. Dance Biopharm Basic Information, Manufacturing Base and Competitors
Table 34. Dance Biopharm Major Business
Table 35. Dance Biopharm Insulin Drug Delivery Devices Product and Services
Table 36. Dance Biopharm Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Dance Biopharm Recent Developments/Updates
Table 38. Roche Basic Information, Manufacturing Base and Competitors
Table 39. Roche Major Business
Table 40. Roche Insulin Drug Delivery Devices Product and Services
Table 41. Roche Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Roche Recent Developments/Updates
Table 43. Tandem Diabetes Care Basic Information, Manufacturing Base and Competitors
Table 44. Tandem Diabetes Care Major Business
Table 45. Tandem Diabetes Care Insulin Drug Delivery Devices Product and Services
Table 46. Tandem Diabetes Care Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Tandem Diabetes Care Recent Developments/Updates
Table 48. Animas Basic Information, Manufacturing Base and Competitors
Table 49. Animas Major Business
Table 50. Animas Insulin Drug Delivery Devices Product and Services
Table 51. Animas Insulin Drug Delivery Devices Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Animas Recent Developments/Updates
Table 53. Global Insulin Drug Delivery Devices Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 54. Global Insulin Drug Delivery Devices Revenue by Manufacturer (2018-2023) & (USD Million)
Table 55. Global Insulin Drug Delivery Devices Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 56. Market Position of Manufacturers in Insulin Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 57. Head Office and Insulin Drug Delivery Devices Production Site of Key Manufacturer
Table 58. Insulin Drug Delivery Devices Market: Company Product Type Footprint
Table 59. Insulin Drug Delivery Devices Market: Company Product Application Footprint
Table 60. Insulin Drug Delivery Devices New Market Entrants and Barriers to Market Entry
Table 61. Insulin Drug Delivery Devices Mergers, Acquisition, Agreements, and Collaborations
Table 62. Global Insulin Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 63. Global Insulin Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 64. Global Insulin Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 65. Global Insulin Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 66. Global Insulin Drug Delivery Devices Average Price by Region (2018-2023) & (USD/Unit)
Table 67. Global Insulin Drug Delivery Devices Average Price by Region (2024-2029) & (USD/Unit)
Table 68. Global Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 69. Global Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 70. Global Insulin Drug Delivery Devices Consumption Value by Type (2018-2023) & (USD Million)
Table 71. Global Insulin Drug Delivery Devices Consumption Value by Type (2024-2029) & (USD Million)
Table 72. Global Insulin Drug Delivery Devices Average Price by Type (2018-2023) & (USD/Unit)
Table 73. Global Insulin Drug Delivery Devices Average Price by Type (2024-2029) & (USD/Unit)
Table 74. Global Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 75. Global Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 76. Global Insulin Drug Delivery Devices Consumption Value by Application (2018-2023) & (USD Million)
Table 77. Global Insulin Drug Delivery Devices Consumption Value by Application (2024-2029) & (USD Million)
Table 78. Global Insulin Drug Delivery Devices Average Price by Application (2018-2023) & (USD/Unit)
Table 79. Global Insulin Drug Delivery Devices Average Price by Application (2024-2029) & (USD/Unit)
Table 80. North America Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 81. North America Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 82. North America Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 83. North America Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 84. North America Insulin Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 85. North America Insulin Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 86. North America Insulin Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 87. North America Insulin Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 88. Europe Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 89. Europe Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 90. Europe Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 91. Europe Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 92. Europe Insulin Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 93. Europe Insulin Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 94. Europe Insulin Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Insulin Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 97. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 98. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 99. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 100. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 101. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 102. Asia-Pacific Insulin Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 103. Asia-Pacific Insulin Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 104. South America Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 105. South America Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 106. South America Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 107. South America Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 108. South America Insulin Drug Delivery Devices Sales Quantity by Country (2018-2023) & (K Units)
Table 109. South America Insulin Drug Delivery Devices Sales Quantity by Country (2024-2029) & (K Units)
Table 110. South America Insulin Drug Delivery Devices Consumption Value by Country (2018-2023) & (USD Million)
Table 111. South America Insulin Drug Delivery Devices Consumption Value by Country (2024-2029) & (USD Million)
Table 112. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Type (2018-2023) & (K Units)
Table 113. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Type (2024-2029) & (K Units)
Table 114. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Application (2018-2023) & (K Units)
Table 115. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Application (2024-2029) & (K Units)
Table 116. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Region (2018-2023) & (K Units)
Table 117. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity by Region (2024-2029) & (K Units)
Table 118. Middle East & Africa Insulin Drug Delivery Devices Consumption Value by Region (2018-2023) & (USD Million)
Table 119. Middle East & Africa Insulin Drug Delivery Devices Consumption Value by Region (2024-2029) & (USD Million)
Table 120. Insulin Drug Delivery Devices Raw Material
Table 121. Key Manufacturers of Insulin Drug Delivery Devices Raw Materials
Table 122. Insulin Drug Delivery Devices Typical Distributors
Table 123. Insulin Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Insulin Drug Delivery Devices Picture
Figure 2. Global Insulin Drug Delivery Devices Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Insulin Drug Delivery Devices Consumption Value Market Share by Type in 2022
Figure 4. Syringes Examples
Figure 5. Insulin Pens Examples
Figure 6. Jet Injectors Examples
Figure 7. Insulin Pumps Examples
Figure 8. Global Insulin Drug Delivery Devices Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Insulin Drug Delivery Devices Consumption Value Market Share by Application in 2022
Figure 10. Hospitals Examples
Figure 11. Clinics Examples
Figure 12. Homecare Examples
Figure 13. Others Examples
Figure 14. Global Insulin Drug Delivery Devices Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Insulin Drug Delivery Devices Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Insulin Drug Delivery Devices Sales Quantity (2018-2029) & (K Units)
Figure 17. Global Insulin Drug Delivery Devices Average Price (2018-2029) & (USD/Unit)
Figure 18. Global Insulin Drug Delivery Devices Sales Quantity Market Share by Manufacturer in 2022
Figure 19. Global Insulin Drug Delivery Devices Consumption Value Market Share by Manufacturer in 2022
Figure 20. Producer Shipments of Insulin Drug Delivery Devices by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 21. Top 3 Insulin Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Top 6 Insulin Drug Delivery Devices Manufacturer (Consumption Value) Market Share in 2022
Figure 23. Global Insulin Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 24. Global Insulin Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 25. North America Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 26. Europe Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 27. Asia-Pacific Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 28. South America Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 29. Middle East & Africa Insulin Drug Delivery Devices Consumption Value (2018-2029) & (USD Million)
Figure 30. Global Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 31. Global Insulin Drug Delivery Devices Consumption Value Market Share by Type (2018-2029)
Figure 32. Global Insulin Drug Delivery Devices Average Price by Type (2018-2029) & (USD/Unit)
Figure 33. Global Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 34. Global Insulin Drug Delivery Devices Consumption Value Market Share by Application (2018-2029)
Figure 35. Global Insulin Drug Delivery Devices Average Price by Application (2018-2029) & (USD/Unit)
Figure 36. North America Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 37. North America Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 38. North America Insulin Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 39. North America Insulin Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 40. United States Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Canada Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Mexico Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 43. Europe Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 44. Europe Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 45. Europe Insulin Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 46. Europe Insulin Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 47. Germany Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. France Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. United Kingdom Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Russia Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Italy Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 52. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 53. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 54. Asia-Pacific Insulin Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 55. Asia-Pacific Insulin Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 56. China Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Japan Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Korea Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. India Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Southeast Asia Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. Australia Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 62. South America Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 63. South America Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 64. South America Insulin Drug Delivery Devices Sales Quantity Market Share by Country (2018-2029)
Figure 65. South America Insulin Drug Delivery Devices Consumption Value Market Share by Country (2018-2029)
Figure 66. Brazil Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Argentina Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 68. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity Market Share by Type (2018-2029)
Figure 69. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity Market Share by Application (2018-2029)
Figure 70. Middle East & Africa Insulin Drug Delivery Devices Sales Quantity Market Share by Region (2018-2029)
Figure 71. Middle East & Africa Insulin Drug Delivery Devices Consumption Value Market Share by Region (2018-2029)
Figure 72. Turkey Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Egypt Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. Saudi Arabia Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. South Africa Insulin Drug Delivery Devices Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 76. Insulin Drug Delivery Devices Market Drivers
Figure 77. Insulin Drug Delivery Devices Market Restraints
Figure 78. Insulin Drug Delivery Devices Market Trends
Figure 79. Porters Five Forces Analysis
Figure 80. Manufacturing Cost Structure Analysis of Insulin Drug Delivery Devices in 2022
Figure 81. Manufacturing Process Analysis of Insulin Drug Delivery Devices
Figure 82. Insulin Drug Delivery Devices Industrial Chain
Figure 83. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 84. Direct Channel Pros & Cons
Figure 85. Indirect Channel Pros & Cons
Figure 86. Methodology
Figure 87. Research Process and Data Source
btl

Research Methodology

Client Requirements

yuan2

Review and analyze client requirements

yuan2

Discussion of all the project requirements and queries

Flexibility Check

yuan2

Project Feasibility Analysis

yuan2

Finalizing tentative research programme

yuan2

Structuring project proposal with scope, timeline, and costs

Analyzing Market Dynamics

yuan2

Determination of key drivers, restraints, challenge, and opportunity

yuan2

Identifies market needs and trends

Market Size Estimation & Forecast

yuan2

Estimation of historical data based on secondary and primary data

yuan2

Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)

yuan2

Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies

yuan2

Consideration of geography, region-specific product/service demand for region segments

yuan2

Consideration of product utilization rates, product demand outlook for segments by application or end-user.

tuBiao1

Data Source

yuan2

Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports, paid database, press releases, blogs, newsletters,and GIR repositories.

yuan2

Discussion of all the project requirements and queries

Validation and triangulation of secondary and primary source.

yuan2

Collection of data

yuan2

Cumulating and collating the essential qualitative and quantitative data

yuan2

Generation of report in client requested format by research analysts

yuan2

Reviews by expert analysts

yuan2

Final quality check

yuan2

Clarifying queries

yuan2

Receiving feedback

yuan2

Ensuring satisfaction

  • yuan01
    liuCheng01

    01 Identification of data

    This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.

  • yuan01
    liuCheng01

    02 Evaluation of Market Dynamic

    This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.

  • yuan01
    liuCheng01

    03 Collection of Data

    This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.

  • yuan01
    liuCheng01

    04 Collaboration of Data

    This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.

  • yuan01
    liuCheng01

    05 Verification and Analysis

    This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.

btl

Companies Mentioned

Novo Nordisk
Sanofi
BD
Eli Lilly
Medtronic
Beta Bionics
Dance Biopharm
Roche
Tandem Diabetes Care
Animas
btl

Related Reports

jiaGou

Add To Cart

gouMai

Buy Now